- Home
- FORR vs COYA Comparison
FORR vs COYA Comparison
Compare FORR & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FORR | COYA |
|---|---|---|
| Founded | 1983 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.6M | 126.6M |
| IPO Year | 1996 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FORR | COYA |
|---|---|---|
| Price | $5.61 | $4.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 130.1K | ★ 202.9K |
| Earning Date | 02-12-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $396,888,000.00 | $3,987,706.00 |
| Revenue This Year | $1.45 | $70.00 |
| Revenue Next Year | $3.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.91 | $3.94 |
| 52 Week High | $13.33 | $8.29 |
Technical Indicators
Market Signals| Indicator | FORR | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 15.63 | 48.92 |
| Support Level | $6.90 | $4.41 |
| Resistance Level | $7.40 | $5.32 |
| Average True Range (ATR) | 0.44 | 0.30 |
| MACD | -0.25 | 0.06 |
| Stochastic Oscillator | 7.71 | 46.70 |
Price Performance
Historical ComparisonAbout FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.